-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Q2E/rhQyR3bBcUii+IWN+myhZXIXLb/6Plpx2i/mREAnfJTdLN2+cVY3HTtno042 2TdwI1qYqewnHOGrqLuqFg== 0001209191-05-001694.txt : 20050105 0001209191-05-001694.hdr.sgml : 20050105 20050105152238 ACCESSION NUMBER: 0001209191-05-001694 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050101 FILED AS OF DATE: 20050105 DATE AS OF CHANGE: 20050105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GUILFORD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000918066 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521841960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6611 TRIBUTARY ST CITY: BALTIMORE STATE: MD ZIP: 21224 BUSINESS PHONE: 4106316300 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KLEIN JOSEPH III CENTRAL INDEX KEY: 0001206369 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23736 FILM NUMBER: 05512367 BUSINESS ADDRESS: BUSINESS PHONE: 2037731450 MAIL ADDRESS: STREET 1: C/O GENAISSANCE PHARMACEUTICALS INC STREET 2: FIVE SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2005-01-01 0 0000918066 GUILFORD PHARMACEUTICALS INC GLFD 0001206369 KLEIN JOSEPH III C/O GENAISSANCE PHARMACEUTICALS INC. FIVE SCIENCE PARK NEW HAVEN CT 06511 1 0 0 0 Restricted Stock Units 0.00 2005-01-01 4 A 0 5878 4.95 A Common Stock 5878 11158 D Stock Options (Right to buy) 5.90 2004-05-13 2013-05-13 Common Stock 7500 7500 D Stock Options (Right to buy) 6.38 2005-05-05 2014-05-05 Common Stock 7500 7500 D Stock Options (Right to buy) 6.85 2003-05-14 2012-05-14 Common Stock 7500 7500 D Stock Options (Right to buy) 16.0625 2001-05-16 2010-05-16 Common Stock 7500 7500 D Stock Options (Right to buy) 16.375 1999-08-17 2008-08-17 Common Stock 15000 15000 D Stock Options (Right to buy) 19.90 2002-05-15 2011-05-15 Common Stock 7500 7500 D Consists of Restricted Stock Units granted under the Company's 2002 Stock Award and Incentive Plan in lieu of cash payment for board retainer and board committee fees, which Restricted Stock Units are 100% vested as of the date of the grant. The Restricted Stock Units will be exchanged for shares of the Company's common stock six months after Mr. Klein retires from the Company's Board of Directors. Asher M. Rubin, Attorney-in-fact 2005-01-05 -----END PRIVACY-ENHANCED MESSAGE-----